One-Year Safety and Performance of a Dual-Chamber Leadless Pacemaker
Circulation: Arrhythmia and Electrophysiology · 2025-04 · 18 (4)
DOI: 10.1161/circep.124.013619 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2025-04. Verfasst von Reinoud E Knops und 16 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, the Netherlands (R.E.K., K.T.N.B.). Hauptthemen laut MEDLINE: Pacemaker, Artificial, Bradycardia, Cardiac Pacing, Artificial, Heart Rate. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: A dual-chamber leadless pacemaker can provide bradycardia therapy to most patients with pacemaker indications without the complications associated with a lead or pulse generator. We sought to confirm whether previously reported 3-month safety and performance outcomes were sustained through 12 months by determining whether 12-month complication-free and performance success rates exceeded their prespecified performance goals. METHODS: Patients were enrolled in the prospective, single-group Aveir DR i2i Study if they had a standard indication for dual-chamber pacing. Enrolled patients were implanted with an Aveir DR dual-chamber leadless pacemaker system, which comprised 2 communicating leadless pacemakers (1 in the right atrium and 1 in the right ventricle). The primary safety outcome evaluated whether freedom from serious device- or procedure-related events through 365 days exceeded the predetermined performance goal of 76.5%. The primary performance outcome determined whether the composite of atrial capture threshold (≤3.0 V at 0.4 ms) and sensing amplitude (P-wave ≥1.0 mV) at the 12-month visit exceeded the predetermined performance goal of 80.0%. RESULTS: Sites attempted implantation in 300 subjects, where 63.3% had sinus-node dysfunction and 33.3% had atrioventricular block as their primary pacing indication. The primary safety end point was achieved, with a Kaplan-Meier 12-month complication-free rate of 88.6% (95% CI, 84.5–91.8; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amsterdam UMC, the Netherlands (R.E.K., K.T.N.B.).
- Weill Cornell Medicine/New York Presbyterian Hospital, NY (J.E.I.).
- HonorHealth Cardiac Arrhythmia Group, Scottsdale, AZ (R.D.).
- Foothills Medical Centre, Calgary, Alberta, Canada (D.V.E.).
- CHRU Albert Michallon, Grenoble, France (P.D.).
- Texas Cardiac Arrhythmia Institute, Austin, TX (R.C.).
ORCID-Profile: Reinoud E Knops, James E Ip, Rahul Doshi, Derek V Exner, Pascal Defaye, Robert Canby, Maria Grazia Bongiorni, Morio Shoda, Gerhard Hindricks, Petr Neužil, Mayer Rashtian, Karel T N Breeman, Jordan R Nevo, Vivek Y Reddy
Zitieren
APA
Knops, R. E., Ip, J. E., Doshi, R., Exner, D. V., Defaye, P., Canby, R., Bongiorni, M. G., Shoda, M., Hindricks, G., Neužil, P., Rashtian, M., Breeman, K. T. N., Nevo, J. R., Ganz, L., Hubbard, C., Bulusu, A., & Reddy, V. Y. (2025). One-Year Safety and Performance of a Dual-Chamber Leadless Pacemaker. Circulation: Arrhythmia and Electrophysiology, 18(4). https://doi.org/10.1161/circep.124.013619
Vancouver
Knops RE, Ip JE, Doshi R, Exner DV, Defaye P, Canby R, et al. One-Year Safety and Performance of a Dual-Chamber Leadless Pacemaker. Circulation: Arrhythmia and Electrophysiology. 2025;18(4). doi:10.1161/circep.124.013619
BibTeX
@article{Knops2025,
author = {Knops, Reinoud E and Ip, James E and Doshi, Rahul and Exner, Derek V and Defaye, Pascal and Canby, Robert and Bongiorni, Maria Grazia and Shoda, Morio and Hindricks, Gerhard and Neužil, Petr and Rashtian, Mayer and Breeman, Karel T N and Nevo, Jordan R and Ganz, Leonard and Hubbard, Chris and Bulusu, Anu and Reddy, Vivek Y},
title = {One-Year Safety and Performance of a Dual-Chamber Leadless Pacemaker},
journal = {Circulation: Arrhythmia and Electrophysiology},
year = {2025},
volume = {18},
number = {4},
doi = {10.1161/circep.124.013619}
}
EUVIMED